PAX6 and aniridia: Mutations and deregulation of PAX6 are associated with aniridia (OMIM 106210), a disorder initially characterized by an absent or underdeveloped iris, among other phenotypes such as defects in the retina, pancreas, and neurological systems [33], which is consistent with PAX6 expression in these tissues and organs [24].